Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria

被引:222
作者
Krolewski, Andrzej S. [1 ,2 ]
Niewczas, Monika A. [1 ,2 ]
Skupien, Jan [1 ,2 ,3 ]
Gohda, Tomhito [1 ,2 ,4 ]
Smiles, Adam [1 ]
Eckfeldt, Jon H. [5 ]
Doria, Alessandro [1 ,2 ]
Warram, James H. [1 ]
机构
[1] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland
[4] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 113, Japan
[5] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
GLOMERULAR-FILTRATION-RATE; TNF RECEPTORS 1; URIC-ACID; BLOOD-PRESSURE; CYSTATIN-C; RISK; DISEASE;
D O I
10.2337/dc13-0985
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEProgressive decrease in the glomerular filtration rate (GFR), or renal decline, in type 1 diabetes (T1D) is observed in patients with macroalbuminuria. However, it is unknown whether this decline begins during microalbuminuria (MA) or normoalbuminuria (NA).RESEARCH DESIGN AND METHODSThe study group (second Joslin Kidney Study) comprises patients with T1D and NA (n = 286) or MA (n = 248) who were followed for 4-10 years (median 8 years). Serial measurements (median 6, range 3-16) of serum creatinine and cystatin C were used jointly to estimate GFR (eGFRcr-cys) and assess its trajectories during follow-up.RESULTSRenal decline (progressive eGFRcr-cys loss of at least 3.3% per year) occurred in 10% of the NA and 35% of the MA (P < 0.001). In both groups, the strongest determinants of renal decline were baseline serum concentrations of uric acid (P < 0.001) and tumor necrosis factor receptor 1 or 2 (TNFR-1 or -2, P < 0.001). Other significant risk factors included baseline HbA(1c), age/diabetes duration, and systolic blood pressure. Relative impacts of these determinants were similar in NA and MA. Renal decline was not associated with sex or baseline serum concentration of TNF-, IL-6, IL-8, IP-10, MCP-1, VCAM, ICAM, Fas, or FasL.CONCLUSIONSRenal decline in T1D begins during NA and it is determined by multiple factors, similar to MA. Thus, this early decline is the primary disease process leading to impaired renal function in T1D. Changes in albumin excretion rate, such as the onset of MA or its progression to macroalbuminuria, are either caused by or develop in parallel to the early renal decline.
引用
收藏
页码:226 / 234
页数:9
相关论文
共 27 条
[1]   Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes [J].
de Boer, Ian H. ;
Sun, Wanjie ;
Cleary, Patricia A. ;
Lachin, John M. ;
Molitch, Mark E. ;
Steffes, Michael W. ;
Zinman, Bernard .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (25) :2366-2376
[2]   Can Existing Drugs Approved for Other Indications Retard Renal Function Decline in Patients With Type 1 Diabetes and Nephropathy? [J].
Doria, Alessandro ;
Niewczas, Monika A. ;
Fiorina, Paolo .
SEMINARS IN NEPHROLOGY, 2012, 32 (05) :437-444
[3]   High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes Results of a 6-year follow-up [J].
Ficociello, Linda H. ;
Rosolowsky, Elizabeth T. ;
Niewczas, Monika A. ;
Maselli, Nicholas J. ;
Weinberg, Janice M. ;
Aschengrau, Ann ;
Eckfeldt, John H. ;
Stanton, Robert C. ;
Galecki, Andrzej T. ;
Doria, Alessandro ;
Warram, James H. ;
Krolewski, Andrzej S. .
DIABETES CARE, 2010, 33 (06) :1337-1343
[4]   Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes [J].
Gohda, Tomohito ;
Niewczas, Monika A. ;
Ficociello, Linda H. ;
Walker, William H. ;
Skupien, Jan ;
Rosetti, Florencia ;
Cullere, Xavier ;
Johnson, Amanda C. ;
Crabtree, Gordon ;
Smiles, Adam M. ;
Mayadas, Tanya N. ;
Warram, James H. ;
Krolewski, Andrzej S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (03) :516-524
[5]   Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C [J].
Inker, Lesley A. ;
Schmid, Christopher H. ;
Tighiouart, Hocine ;
Eckfeldt, John H. ;
Feldman, Harold I. ;
Greene, Tom ;
Kusek, John W. ;
Manzi, Jane ;
Van Lente, Frederick ;
Zhang, Yaping Lucy ;
Coresh, Josef ;
Levey, Andrew S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (01) :20-29
[6]   Essential hypertension, progressive renal disease, and uric acid:: A pathogenetic link? [J].
Johnson, RJ ;
Segal, MS ;
Srinivas, T ;
Ejaz, A ;
Mu, W ;
Roncal, C ;
Sánchez-Lozada, LG ;
Gersch, M ;
Rodriguez-Iturbe, B ;
Kang, DH ;
Acosta, JH .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :1909-1919
[7]   A role for uric acid in the progression of renal disease [J].
Kang, DH ;
Nakagawa, T ;
Feng, LL ;
Watanabe, S ;
Han, L ;
Mazzali, M ;
Truong, L ;
Harris, R ;
Johnson, RJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (12) :2888-2897
[8]   Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes [J].
Krolewski, Andrzej S. ;
Warram, James H. ;
Forsblom, Carol ;
Smiles, Adam M. ;
Thorn, Lena ;
Skupien, Jan ;
Harjutsalo, Valma ;
Stanton, Robert ;
Eckfeldt, John H. ;
Inker, Lesley A. ;
Groop, Per-Henrik .
DIABETES CARE, 2012, 35 (11) :2311-2316
[9]   LONGITUDINAL-STUDIES ON THE RATE OF DECLINE IN RENAL-FUNCTION WITH AGE [J].
LINDEMAN, RD ;
TOBIN, J ;
SHOCK, NW .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1985, 33 (04) :278-285
[10]   Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes. [J].
Mauer, Michael ;
Zinman, Bernard ;
Gardiner, Robert ;
Suissa, Samy ;
Sinaiko, Alan ;
Strand, Trudy ;
Drummond, Keith ;
Donnelly, Sandra ;
Goodyer, Paul ;
Gubler, Marie Claire ;
Klein, Ronald .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :40-51